
1. Enferm Infecc Microbiol Clin. 2019 Mar;37(3):195-202. doi:
10.1016/j.eimc.2018.02.010. Epub 2018 Jun 18.

Executive summary of the GeSIDA/National AIDS Plan consensus document on
antiretroviral therapy in adults infected by the human immunodeficiency virus
(updated January 2018).

[Article in English, Spanish]

AIDS Study Group (GeSIDA) of the Spanish Society of Infectious Diseases and
Clinical Microbiology and the National AIDS Plan:.

Collaborators: Pérez-Molina JA(1), Polo R(2), López-Aldeguer J(3), Lozano F(4),
Aguirrebengoa K(5), Arribas JR(6), Boix V(7), Berenguer J(8), Blanco JR(9),
Domingo P(10), Estrada V(11), Galindo MJ(12), García F(13), Gatell JM(14),
González-García J(6), Gutiérrez F(15), Iribarren JA(16), Knobel H(17), Llibre
JM(18), López-Bernaldo de Quirós JC(8), López-Cortés LF(19), Losa JE(20), Mariño 
A(21), Miró JM(14), Montes ML(6), Moreno S(1), Negredo E(18), Pérez-Elías MJ(1), 
Podzamczer D(22), Portilla J(7), Poveda E(23), Pulido F(24), Ribera E(25), Rivero
A(26), Rubio R(24), Santos J(27), Sanz-Moreno J(28), Sanz-Sanz J(29), Serrano
S(1), de la Torre J(30), Tuset M(31), von Wichman MA(32), Martínez E(31).

Author information: 
(1)Hospital Ramón y Cajal - IRYCIS, Madrid, Spain.
(2)Secretaría del Plan Nacional sobre el Sida, Ministerio de Sanidad, Servicios
Sociales e Igualdad, Madrid, Spain.
(3)Hospital Universitario La Fe - IISLaFe, Valencia, Spain.
(4)Hospital Universitario Virgen de Valme, Sevilla, Spain. Electronic address:
fernandolozano@telefonica.net.
(5)Hospital Universitario Cruces, Bilbao, Spain.
(6)Hospital Universitario La Paz - IdiPAZ, Madrid, Spain.
(7)Hospital General Universitario, Alicante, Spain.
(8)Hospital General Universitario Gregorio Marañón, Madrid, Spain.
(9)Hospital San Pedro - CIBIR, Logroño, Spain.
(10)Hospitals Universitaris Arnau de Vilanova i Santa Maria, Universitat de
Lleida, IRB-Lleida, Lleida, Spain.
(11)Hospital Clínico San Carlos, Madrid, Spain.
(12)Hospital Clínico Universitario, Valencia, Spain.
(13)Hospital Universitario San Cecilio, Granada, Spain.
(14)Hospital Clínic Universitari - IDIBAPS, UB, Barcelona, Spain.
(15)Hospital General Universitario de Elche y Universidad Miguel Hernández de
Alicante, Spain.
(16)Hospital Universitario Donostia, Instituto Biodonostia, San Sebastián, Spain.
(17)Hospital del Mar, Barcelona, Spain.
(18)Hospital Germans Trías i Pujol, Badalona, Spain.
(19)Hospital Universitario Virgen del Rocío - IBIS, Sevilla, Spain.
(20)Hospital Universitario Fundación Alcorcón, Madrid, Spain.
(21)Complejo Hospitalario Universitario de Ferrol, Spain.
(22)IDIBELL - Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain.
(23)Complejo Hospitalario Universitario - INIBIC, A Coruña, Spain.
(24)Hospital Universitario 12 de Octubre, Madrid, Spain.
(25)Hospital Universitari Vall de Hebron, Barcelona, Spain.
(26)Hospital Universitario Reina Sofía, Córdoba, Spain.
(27)Hospital Universitario Virgen de la Victoria - IBIMA, Málaga, Spain.
(28)Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid,
Spain.
(29)Hospital Universitario de la Princesa, Madrid, Spain.
(30)Hospital Costa del Sol, Marbella, Spain.
(31)Hospital Clinic Universitari - IDIBAPS, UB, Barcelona, Spain.
(32)Hospital Universitario Donostia - Instituto Biodonostia, San Sebastián,
Spain.

This update to the document on antiretroviral therapy (ART) in adults, which has 
been prepared jointly by GeSIDA and the Spanish National AIDS Plan for the last
two decades, supersedes the document published in 2017.1 The update provides
physicians treating HIV-1-infected adults with evidence-based recommendations to 
guide their therapeutic decisions. The main difference with respect to the
previous document concerns recommended initial ART regimens, only three of which 
are maintained as preferential. All three include dolutegravir or raltegravir,
together with emtricitabine/tenofovir alafenamide or abacavir/lamivudine. Other
differences concern the section on switching ART in patients with suppressed
viral replication, which now includes new two- and three-drug regimens, and the
antiretroviral drugs recommended for pregnant women and patients with
tuberculosis. A recommendation has also been added for patients who present with 
acute HIV infection after pre-exposure prophylaxis.

Copyright © 2018 Elsevier España, S.L.U. and Sociedad Española de Enfermedades
Infecciosas y Microbiología Clínica. All rights reserved.

DOI: 10.1016/j.eimc.2018.02.010 
PMID: 29759422  [Indexed for MEDLINE]

